Latest news with #MostInnovativeCompanies2025
Hans India
2 days ago
- Business
- Hans India
Innovation Takes Centre Stage: 95% of Indian Companies Rank It Among Top 3 Priorities
Amid ongoing economic and geopolitical turbulence, a new report from Boston Consulting Group (BCG) reveals that innovation resilience is a defining trait of high-performing firms. The report, titled Most Innovative Companies 2025: In Disruptive Times, the Resilient Win, explores insights from two decades of BCG's innovation research. Based on an analysis of the firms that have appeared on BCG's annual 50 Most Innovative Companies lists since 2005, the report found a strong link between long-term innovation excellence and total shareholder return (TSR). Top innovators outperformed the broader market by 2.4 percentage points annually on average, with particularly strong gains during the Great Recession and the COVID-19 pandemic. Yet while innovation has remained a top-three priority for 64% to 83% firms every year, many companies aren't up to the task. From 2021 to 2024, the proportion of executives who said that they see their companies as innovation leaders declined by 24 percentage points. And despite continued high R&D spending, the report found no consistent link between R&D investment and TSR. 'The ability to innovate through adversity is what separates exceptional companies from the rest,' said Justin Manly, a BCG managing director and senior partner and a coauthor of the report. 'R&D spending alone isn't enough. What matters most is investing in the right initiatives and capabilities to turn uncertainty into opportunity.' Asian Innovators Gain Prominence, Europe Falters China & India leads in innovation prioritization with 95% of its respondents' reporting innovation as a top three priority in 2024—the most of any region apart from India, which also came in at 95%. In 2005, no Chinese companies appeared in BCG's top 50 ranking. By 2023, Chinese companies held 8 of the 50 slots (16% of the total list)—including 2 of the top 10. Meanwhile, since 2005, North American companies have seen their share fall from nearly three-quarters of the list to about half, although they still represent two-thirds of all serial innovators—firms that have ranked on the list 10 or more times. In contrast, European companies have had less staying power. European companies typically rank lower on the top 50 list, and Europe also accounts for the highest share of companies that have appeared on the list only once. Compared to other regions, Europe's most innovative companies tend to skew toward industrial sectors such as automotive and pharma, rather than technology. Digital Maturity Defines Today's Innovation Leaders Digital maturity has become table stakes for innovation success. BCG's analysis of corporate earnings call transcripts found that mentions of digital innovation doubled from 2005 to 2024. The 25 serial innovators that have ranked 10+ times in the top 50 referenced digital topics nearly four times as often as their peers did. Nevertheless, digital innovation excellence remains a moving target. In 2024, AI and GenAI captured more than 80% of all venture capital investment. And agentic AI is set to raise the innovation bar again. A New C-Suite Agenda for Innovation As companies face increased geopolitical uncertainty, the report outlines four questions to help business leaders prepare for a potential post-globalization world: Ambition. How do we adjust our innovation targets as profit pools shift? Portfolio. Which projects should we prioritize, redesign, or discontinue to reduce exposure or tap into new opportunities? Talent. What talent constraints or opportunities are likely to arise? Footprint. Do our innovation centers need reshaping to build resilience? 'The best innovators don't just weather the storm—they redesign the ship while sailing through it,' said Amy MacDougall, a BCG partner and a coauthor of the report. 'This is the moment for bold action to future-proof innovation systems.' About Boston Consulting Group Boston Consulting Group partners with leaders in business and society to tackle their most important challenges and capture their greatest opportunities. BCG was the pioneer in business strategy when it was founded in 1963. Today, we work closely with clients to embrace a transformational approach aimed at benefiting all stakeholders—empowering organizations to grow, build sustainable competitive advantage, and drive positive societal impact. Our diverse, global teams bring deep industry and functional expertise and a range of perspectives that question the status quo and spark change. BCG delivers solutions through leading-edge management consulting, technology and design, and corporate and digital ventures. We work in a uniquely collaborative model across the firm and throughout all levels of the client organization, fueled by the goal of helping our clients thrive and enabling them to make the world a better place.
Time of India
2 days ago
- Business
- Time of India
Innovation tops agenda: 95% of Indian firms list it in top 3 priorities
Amid ongoing economic and geopolitical turbulence, a new report from Boston Consulting Group (BCG) reveals that innovation resilience is a defining trait of high-performing firms. The report, titled Most Innovative Companies 2025: In Disruptive Times, the Resilient Win , explores insights from two decades of BCG's innovation research. Based on an analysis of the firms that have appeared on BCG's annual 50 Most Innovative Companies lists since 2005, the report found a strong link between long-term innovation excellence and total shareholder return (TSR). Top innovators outperformed the broader market by 2.4 percentage points annually on average, with particularly strong gains during the Great Recession and the COVID-19 pandemic. Yet while innovation has remained a top-three priority for 64% to 83% firms every year, many companies aren't up to the task. From 2021 to 2024, the proportion of executives who said that they see their companies as innovation leaders declined by 24 percentage points. And despite continued high R&D spending, the report found no consistent link between R&D investment and TSR. 'The ability to innovate through adversity is what separates exceptional companies from the rest,' said Justin Manly , a BCG managing director and senior partner and a coauthor of the report. 'R&D spending alone isn't enough. What matters most is investing in the right initiatives and capabilities to turn uncertainty into opportunity.' Asian innovators gain prominence, europe falters China & India leads in innovation prioritization with 95% of its respondents reporting innovation as a top three priority in 2024—the most of any region apart from India, which also came in at 95%. In 2005, no Chinese companies appeared in BCG's top 50 ranking. By 2023, Chinese companies held 8 of the 50 slots (16% of the total list)—including 2 of the top 10. Meanwhile, since 2005, North American companies have seen their share fall from nearly three-quarters of the list to about half, although they still represent two-thirds of all serial innovators—firms that have ranked on the list 10 or more times. In contrast, European companies have had less staying power. European companies typically rank lower on the top 50 list, and Europe also accounts for the highest share of companies that have appeared on the list only once. Compared to other regions, Europe's most innovative companies tend to skew toward industrial sectors such as automotive and pharma, rather than technology. Digital maturity defines today's innovation leaders Digital maturity has become table stakes for innovation success. BCG's analysis of corporate earnings call transcripts found that mentions of digital innovation doubled from 2005 to 2024. The 25 serial innovators that have ranked 10+ times in the top 50 referenced digital topics nearly four times as often as their peers did. Nevertheless, digital innovation excellence remains a moving target. In 2024, AI and GenAI captured more than 80% of all venture capital investment. And agentic AI is set to raise the innovation bar again. A new C-suite agenda for innovation As companies face increased geopolitical uncertainty, the report outlines four questions to help business leaders prepare for a potential post-globalization world: Ambition. How do we adjust our innovation targets as profit pools shift? Portfolio. Which projects should we prioritize, redesign, or discontinue to reduce exposure or tap into new opportunities?Talent. What talent constraints or opportunities are likely to arise? Footprint. Do our innovation centers need reshaping to build resilience? 'The best innovators don't just weather the storm—they redesign the ship while sailing through it,' said Amy MacDougall , a BCG partner and a coauthor of the report. 'This is the moment for bold action to future-proof innovation systems.'>
Yahoo
31-03-2025
- Business
- Yahoo
Assurant Named One of America's Most Innovative Companies by Fortune for Third Consecutive Year
ATLANTA, March 26, 2025--(BUSINESS WIRE)--Assurant, Inc. (NYSE: AIZ), a premier global protection company that safeguards and services connected devices, homes and automobiles in partnership with the world's leading brands, has been recognized on Fortune's list of America's Most Innovative Companies 2025. Presented by Fortune and Statista Inc., the world-leading statistics portal and industry ranking provider, this marks the third consecutive year Assurant has been honored with this prestigious recognition. Fortune and Statista selected America's Most Innovative Companies 2025 based on product innovation, process innovation, and innovation culture. For the evaluation of the innovation culture and the internal view of process innovation, Statista deployed online surveys where employees could score their own company on a scale system. For the evaluation of the external view of process innovation as well as product innovation, Statista surveyed experts in various fields – from recruiters to management consultants and patent attorneys. For the evaluation of the intellectual property (IP) portfolio, Statista cooperated with LexisNexis PatentSight and used its platform to analyze the quantity and value of a company's patents. Assurant is proud to be among the 300 highest-scoring U.S. companies awarded America's Most Innovative Companies 2025. "This recognition underscores our relentless pursuit of growth for Assurant and our clients by leveraging innovation to defend, develop, and disrupt our business," said Keith Demmings, president and CEO, Assurant. "Our ability to anticipate and adapt to the evolving needs of our clients and customers is key to our success. We are honored to receive this accolade and remain committed to fostering a culture of innovation that inspires new ideas and solutions to help people thrive in a connected world." "Rooted in an enterprise-wide culture and leveraging the creativity, expertise, and vision of team members across the organization, innovation is foundational to driving differentiation and strengthening our competitive advantage," said Manny Becerra, chief innovation officer, Assurant. "At Assurant, we think of innovation as more than what we deliver in the form of products and services—it's also about how we leverage emerging technologies to specialize experiences for the customers we serve." Assurant holds 215 registered patents and has 193 pending patent applications across 20 countries. From data analytics to next-generation mobile device evaluation techniques, the patent portfolio extends across all major Assurant lines of business and from administrative processes to front-line consumer touchpoints. About AssurantAssurant, Inc. (NYSE: AIZ) is a premier global protection company that partners with the world's leading brands to safeguard and service connected devices, homes, and automobiles. As a Fortune 500 company operating in 21 countries, Assurant leverages data-driven technology solutions to provide exceptional customer experiences. Learn more at View source version on Contacts Media Contact: Stacie ShererVP,
Yahoo
26-03-2025
- Business
- Yahoo
Cognizant Named to Fortune's America's Most Innovative Companies 2025 List
Company recognized for product and process innovation and culture for the third consecutive year TEANECK, N.J., March 26, 2025 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) today announced that it has been recognized on Fortune's list of "America's Most Innovative Companies 2025". This prestigious award is presented by Fortune and Statista Inc., the world-leading statistics portal and industry ranking provider, and recognizes organizations that lead the charge in fostering creativity, advancing technology, and driving transformational change. The awards list was announced on March 26, 2025, and can be viewed on the Fortune website. Fortune and Statista selected America's Most Innovative Companies 2025 based on product innovation, process innovation, and innovation culture. For the evaluation of the innovation culture and the internal view of process innovation, Statista deployed online surveys where employees could score their own company on a scale system. Statista surveyed recruiters, management consultants, and patent attorneys to evaluate the external view of process innovation and product innovation. Statista also cooperated with LexisNexis PatentSight and used its platform to analyze the quantity and value of a company's patents. The 300 companies with the highest score were awarded America's Most Innovative Companies 2025. "Cognizant is proud to be named one of America's Most Innovative Companies for the third consecutive year by Fortune and Statista," said Surya Gummadi, President, Americas, Cognizant. "Over the last few years, Cognizant has prioritized becoming an employer of choice, optimizing operations, and accelerating growth—all while empowering our associates to drive grassroots innovation. That momentum is fueling innovation across the organization and for our clients, positioning Cognizant to lead in the AI era." Statista publishes hundreds of worldwide industry rankings and company listings with high-profile media partners. This research and analysis service is based on the success of the leading data and business intelligence portal that provides statistics, relevant business data, and various market and consumer studies and surveys. About CognizantCognizant (Nasdaq: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we're improving everyday life. See how at or @cognizant. For more information, contact:U.S. Name Bill Abelson Email Europe / APAC Name Christina Schneider Email Name Rashmi Vasisht Email View original content to download multimedia: SOURCE Cognizant Sign in to access your portfolio
Globe and Mail
18-03-2025
- Business
- Globe and Mail
DarwinHealth Recognized and Honored as One of the Top 10 Most Innovative Biotech Companies: Named to Fast Company's Prestigious Annual List of the World's Most Innovative Companies of 2025
NEW YORK , /CNW/ -- DarwinHealth is proud to have been named to Fast Company's prestigious list of the World's Most Innovative Companies of 2025. This year's list shines a spotlight on businesses that are shaping research, industry, and the human condition through their unique innovations in artificial intelligence and other advances that set new standards and achieve remarkable milestones. Alongside the World's 50 Most Innovative Companies, Fast Company recognizes only the top 10 companies for each of 58 sectors. DarwinHealth was honored as one of the 10 most innovative biotech companies in the Most Innovative Companies 2025 competition. "We deploy unique algorithmic (VIPER) and experimental (Patient-to-Model-to-Patient, PMP) technologies that can precisely identify a recurrent, druggable molecular architecture comprised of tumor checkpoints," explained DarwinHealth's CSO Mariano Alvarez who co-developed the foundational algorithm that undergirds the company's research engine. "VIPER is an algorithm based on artificial intelligence that assesses protein activity, a critical step in discovering novel cancer targets and elucidating drug mechanism-of-action." To rank honorees from among thousands of submissions, and using the benchmarks of excellence, forward-thinking, and creativity as its vetting polestar, Fast Company's editors and writers reviewed companies driving progress around the world through a highly competitive application process. The result is a globe-spanning guide to innovation today, from early-stage startups to some of the most valuable companies in the world. On March 18, 2025 , DarwinHealth joined the ranks of such biotech companies as Flagship Pioneering, Insilico Medicine, and Exscientia, previously recognized in the Fast Company competition for leveraging AI in pursuit of developing precision-based therapies for multiple disease states, including cancer. "Our widely published innovations and clinical trials focus on the massive unmet need for cancer patients who have been unresponsive to standard-of-care, guideline-directed therapy, with the objective of extending quality survival in patients in whom other therapies have failed," explains CEO and co-founder Gideon Bosker , MD. "Because of the aforementioned innovations, which have been validated in top-tier scientific and medical journals, DarwinHealth's clinical grade technology is now being used in hundreds of cancer patients in U.S. and Europe , powering multiple clinical trials in rare and treatment-orphan malignancies, including renal, pancreatic, neuroendocrine, prostate, and brain cancer." DarwinHealth's recognition and emergence as one of Fast Company's Most Innovative Companies (MIC) in the biotech sector is based primarily on creating innovative bioplatforms and translational through lines that merge AI/computational rigor with wet lab validations and, ultimately, peer-reviewed publications demonstrating confirmation in clinical settings. Writing in the March 18, 2025 online posting of the Fast Company MIC list, Adam Bluestein notes the 10 companies recognized in the biotech sector "are changing how we discover new drugs and treat complex diseases," adding that DarwinHealth "uses AI—its VIPER algorithm—to take experimentally measurable data from a patient's tumor, such as gene expression profiles, and make predictions about which existing drugs are most likely to be effective against the 'Tumor CheckPoint' proteins driving their particular type of cancer . . . Trial results published in 2024 showed 100% accuracy of the DarwinOncoTarget tool at predicting response to drugs called HDAC6 inhibitors in breast cancer, and a 91% accuracy of DarwinOncoTreat at predicting response of multiple tumor types." "Along with our academic and biopharma partners, DarwinHealth is addressing the expanding unmet need for data-driven drug and target discovery using novel AI algorithms combined with experimental data and validations," explained DarwinHealth co-founder Andrea Califano , whose Lab at Columbia University developed the core technology, and who is currently President of the CHAN ZUCKERBERG BioHub ( New York ). "AI algorithms at DarwinHealth that rely on super-computing horsepower, reverse-engineering of regulatory networks for cancer and other disease states such as diabetes, viral infections, immune disorder, and degenerative brain disease are driving the development of novel bioplatforms with extraordinary predictive powers in the context of drug development." "Our list of the Most Innovative Companies offers both a comprehensive look at innovation today and a playbook for the future," said Fast Company editor-in-chief Brendan Vaughan . "This year, we recognize companies that are harnessing AI in deep and meaningful ways . . . and that are introducing bold ideas . . . At a time when the world is rapidly shifting, these companies are charting the way forward." About DarwinHealth DarwinHealth: Precision Therapeutics for Cancer Medicine is a clinical grade, "frontiers of cancer," biotechnology-focused company, co-founded by CEO Gideon Bosker , MD, and Professor Andrea Califano , Professor of Chemical Systems Biology at Columbia University , and President, CHAN ZUCKERBERG BioHub, New York . The company's technology was developed by the Califano lab over the past 15 years and is exclusively licensed from Columbia University. DarwinHealth utilizes proprietary, systems biology algorithms to match virtually every cancer patient with the drugs and drug combinations that are most likely to produce a successful treatment outcome. "Conversely, these same algorithms also can prioritize investigational drugs and compound combinations of unknown potential against a full spectrum of human malignancies, as well as novel cancer targets," explained Dr. Bosker, "which make them invaluable for pharmaceutical companies seeking to both optimize their compound pipelines and discover mechanistically actionable, novel cancer targets and compound-tumor alignments." DarwinHealth's mission statement is to deploy novel technologies rooted in AI and systems biology to improve clinical outcomes of cancer treatment and other disease states. Its core technology, the VIPER algorithm, can identify tightly knit modules of master regulator proteins that represent a new class of actionable therapeutic targets in cancer. The methodology is applied along two complementary axes: First, DarwinHealth's technologies support the systematic identification and validation of druggable targets at a more foundational, deep state of the cancer cell's regulatory logic so we and our scientific partners can exploit next generation actionability based on more universal tumor dependencies and mechanisms. Second, from a drug development and discovery perspective, the same technologies are capable of identifying potentially druggable novel targets based on master regulators, and upstream modulators of those targets. This "oncotectural" approach, with its emphasis on elucidating and targeting tumor checkpoints, provides novel solutions, mechanistic validations, and positioning roadmaps for advancing precision-focused cancer drug discovery and therapeutics. For more information, please visit:
